Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study
Introduction For people with type 2 diabetes mellitus (T2DM) who require an antidiabetic drug as an add-on to metformin, there is controversy about whether newer drug classes such as dipeptidyl peptidase-4 inhibitors (DPP4i) or sodium-glucose co-transporter-2 inhibitors (SGLT2i) reduce the risk of l...
Main Authors: | Bidulka, P, O'Neill, S, Basu, A, Wilkinson, S, Silverwood, RJ, Charlton, P, Briggs, A, Adler, AI, Khunti, K, Tomlinson, LA, Smeeth, L, Douglas, IJ, Grieve, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2021
|
Similar Items
-
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data
by: Bidulka, P, et al.
Published: (2024) -
Towards derivation of a distinct signature permitting personalised treatment in prostate cancer
by: Lamb, A, et al.
Published: (2012) -
Towards derivation of a distinct signature permitting personalised treatment in prostate cancer
by: Lamb, A, et al.
Published: (2013) -
Implementation of personalised medicine policies in mental healthcare: results from a stated preference study in the UK
by: Alan J. McMichael, et al.
Published: (2022-03-01) -
Editorial on polygenic risk scores - colloquium held at the Centre for Personalised Medicine, Oxford
by: Dixon, P, et al.
Published: (2023)